BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26230297)

  • 1. Clinicopathological significance of ALDH1A1 in lung, colorectal, and breast cancers: a meta-analysis.
    Zhou Y; Wang Y; Ju X; Lan J; Zou H; Li S; Qi Y; Jia W; Hu J; Liang W; Zhang W; Pang L; Li F
    Biomark Med; 2015; 9(8):777-90. PubMed ID: 26230297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry.
    Yang W; Wang Y; Wang W; Chen Z; Bai G
    Med Sci Monit; 2018 May; 24():2864-2872. PubMed ID: 29748529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined expression of aldehyde dehydrogenase 1A1 and β-catenin is associated with lymph node metastasis and poor survival in breast cancer patients following cyclophosphamide treatment.
    Sun M; Zhao H; Xiao Q; Yu Z; Song Z; Yao W; Tang H; Guan S; Jin F; Wei M
    Oncol Rep; 2015 Dec; 34(6):3163-73. PubMed ID: 26398662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent.
    Sjöström M; Hartman L; Honeth G; Grabau D; Malmström P; Hegardt C; Fernö M; Niméus E
    J Clin Pathol; 2015 Dec; 68(12):1012-9. PubMed ID: 26175266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis.
    Liu Y; Lv DL; Duan JJ; Xu SL; Zhang JF; Yang XJ; Zhang X; Cui YH; Bian XW; Yu SC
    BMC Cancer; 2014 Jun; 14():444. PubMed ID: 24938375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
    Li X; Wan L; Geng J; Wu CL; Bai X
    J Thorac Oncol; 2012 Aug; 7(8):1235-45. PubMed ID: 22617249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of ALDH1A1 expression in early invasive breast cancer.
    Althobiti M; El Ansari R; Aleskandarany M; Joseph C; Toss MS; Green AR; Rakha EA
    Histopathology; 2020 Sep; 77(3):437-448. PubMed ID: 32369651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
    Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
    Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldehyde dehyderogenase (ALDH1A1) delineating the normal and cancer stem cells in spectral lung lesions: An immunohistochemical appraisal.
    Yassin Fel-Z
    Pathol Res Pract; 2016 May; 212(5):398-409. PubMed ID: 26907783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer.
    van der Waals LM; Borel Rinkes IHM; Kranenburg O
    PLoS One; 2018; 13(10):e0205536. PubMed ID: 30308036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear aldehyde dehydrogenase 1A1 (ALDH1A1) expression is a favorable prognostic indicator in colorectal carcinoma.
    Wang L; Lin D; Fu Y; Lai M
    Pathol Res Pract; 2016 Sep; 212(9):791-9. PubMed ID: 27461829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer.
    Aguilera Ó; González-Sancho JM; Zazo S; Rincón R; Fernández AF; Tapia O; Canals F; Morte B; Calvanese V; Orgaz JL; Niell N; Aguilar S; Freije JM; Graña O; Pisano DG; Borrero A; Martínez-Useros J; Jiménez B; Fraga MF; García-Foncillas J; López-Otín C; Lafarga M; Rojo F; Muñoz A
    Oncotarget; 2015 Mar; 6(8):5903-17. PubMed ID: 25788273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells.
    Zhao D; Mo Y; Li MT; Zou SW; Cheng ZL; Sun YP; Xiong Y; Guan KL; Lei QY
    J Clin Invest; 2014 Dec; 124(12):5453-65. PubMed ID: 25384215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Chen J; Xia Q; Jiang B; Chang W; Yuan W; Ma Z; Liu Z; Shu X
    PLoS One; 2015; 10(12):e0145164. PubMed ID: 26682730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinical Significance of Cancer Stem Cell Markers ALDH1A1 and CD133 in Lung Adenocarcinoma.
    Miyata T; Oyama T; Yoshimatsu T; Higa H; Kawano D; Sekimura A; Yamashita N; So T; Gotoh A
    Anticancer Res; 2017 May; 37(5):2541-2547. PubMed ID: 28476825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression analysis of aldehyde dehydrogenase 1A1 (ALDH1A1) in colon and rectal cancer in association with prognosis and response to chemotherapy.
    Kahlert C; Gaitzsch E; Steinert G; Mogler C; Herpel E; Hoffmeister M; Jansen L; Benner A; Brenner H; Chang-Claude J; Rahbari N; Schmidt T; Klupp F; Grabe N; Lahrmann B; Koch M; Halama N; Büchler M; Weitz J
    Ann Surg Oncol; 2012 Dec; 19(13):4193-201. PubMed ID: 22878609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal adenoma stem-like cell populations: associations with adenoma characteristics and metachronous colorectal neoplasia.
    Bartley AN; Parikh N; Hsu CH; Roe DJ; Buckmeier JA; Corley L; Phipps RA; Gallick G; Lance P; Thompson PA; Hamilton SR
    Cancer Prev Res (Phila); 2013 Nov; 6(11):1162-70. PubMed ID: 24008128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance.
    He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y
    Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary breast tumor levels of suspected molecular determinants of cellular sensitivity to cyclophosphamide, ifosfamide, and certain other anticancer agents as predictors of paired metastatic tumor levels of these determinants. Rational individualization of cancer chemotherapeutic regimens.
    Sreerama L; Sládek NE
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):255-62. PubMed ID: 11320670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Garcinol from Garcinia indica Downregulates Cancer Stem-like Cell Biomarker ALDH1A1 in Nonsmall Cell Lung Cancer A549 Cells through DDIT3 Activation.
    Wang J; Wang L; Ho CT; Zhang K; Liu Q; Zhao H
    J Agric Food Chem; 2017 May; 65(18):3675-3683. PubMed ID: 28420235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.